Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.
about
Mouse models for radiation-induced cancersMouse models for efficacy testing of agents against radiation carcinogenesis—a literature reviewRb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent mannerTargeting the RB-E2F pathway in breast cancermiR-1279, miR-548j, miR-548m, and miR-548d-5p binding sites in CDSs of paralogous and orthologous PTPN12, MSH6, and ZEB1 GenesMultilayer control of the EMT master regulators.Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts.Regulation of miR106b cluster through the RB pathway: mechanism and functional targets.Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progressionPrognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.Direct RNA sequencing mediated identification of mRNA localized in protrusions of human MDA-MB-231 metastatic breast cancer cellsKLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via ZebThe ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.Progress with palbociclib in breast cancer: latest evidence and clinical considerations.ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma.Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition.Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION.AKT primes snail-induced EMT concomitantly with the collective migration of squamous cell carcinoma cells.A survey of zeb1, twist and claudin 1 and 4 expression during placental development and disease.Prospects for new lung cancer treatments that target EMT signaling.Retinoblastoma protein determines aggressiveness in triple-negative breast cancer.The zinc finger E-box-binding homeobox 1 (Zeb1) promotes the conversion of mouse fibroblasts into functional neurons.p16INK4A induces senescence and inhibits EMT through microRNA-141/microRNA-146b-5p-dependent repression of AUF1.Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.
P2860
Q26747129-CC772D7B-D42B-4133-A552-04E454EA9EABQ26999068-A5CF3AD3-3D87-417D-B820-663FFD6C1C49Q27301808-25CB5C56-CB34-40F0-BD85-5314AFFD5234Q28069626-F59D9BB1-7840-455B-A198-DBA0F6BC670CQ28690612-E34A705F-A166-447E-B62E-49493673C4B9Q34340552-116468CE-35C2-4E18-AFA7-61E73DDA989BQ35051875-631800BE-2824-4584-8E91-B37023F0BA0AQ35157633-5943047F-D2DF-450F-ADC2-89196666F459Q35752332-59FF5DA3-E97B-40B6-A970-C630C6F6B5AFQ35837201-5282BE3B-CC13-489E-AF6E-FB3C0704E044Q36604665-3C3CC77A-0D6E-4E45-87CF-EC05C9091D73Q36727409-07D523D6-D30F-4D88-9AC5-97E0A2E1C1F7Q37030764-B54F988F-2C6D-439E-8370-94C506A3964FQ37351886-93AA3AA0-3FBB-4E5C-A2B3-E9154BD21B25Q37469496-E5A77FEE-169B-4478-BFD9-99AF3D5BE260Q37473157-6F0CD40B-616F-477E-8C46-BC13CB3277E0Q37583488-A3FC0A05-19C0-4FE4-9E47-C39809E4D02AQ37632170-9DF5392E-C6D2-4F9A-9D96-D42034F55910Q38023321-15B03757-CDF9-416E-ACFD-FA3D0F07739DQ38077510-C5E42874-5DB3-4BCA-8CE7-7684E617044CQ38216326-FB344783-7120-434E-B6B7-CBF20068C632Q38367095-0DCB889E-9C0E-4C3E-80F9-7FD93424CC38Q38850621-36CBB178-568E-431B-9693-75BD1D17DC1AQ38918661-3DC880E2-D23A-4A69-AE6D-3D6D5056C8FEQ38953751-4F962E4B-736E-4C89-8887-1AEAD364FCCCQ38980944-71A10B3B-7CAD-4074-A608-E11946DA815AQ39089907-C4384D93-DF3C-4058-880E-2CD9D7005E98Q39171858-1745CC1B-AC64-4E27-9257-DF871B0290BBQ45853725-C1BB9DB8-B2DD-4E23-AEE6-4216F8E781A6Q48271468-F175327D-D941-40A1-A177-0625F31EFA34Q49185712-C9B2CE41-C3AF-4884-BEC7-469296D75FE4Q50438221-AA3AD7D9-8AD1-44C7-BF9C-4180EE93D119Q51532861-5E6B7FA9-E0E6-4D3A-A932-D32867094E38Q53227586-6E285178-9300-42BD-A173-6F83D2DD8E8A
P2860
Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Induction of ZEB proteins by i ...... al phenotype of breast cancer.
@ast
Induction of ZEB proteins by i ...... al phenotype of breast cancer.
@en
type
label
Induction of ZEB proteins by i ...... al phenotype of breast cancer.
@ast
Induction of ZEB proteins by i ...... al phenotype of breast cancer.
@en
prefLabel
Induction of ZEB proteins by i ...... al phenotype of breast cancer.
@ast
Induction of ZEB proteins by i ...... al phenotype of breast cancer.
@en
P2093
P2860
P356
P1476
Induction of ZEB proteins by i ...... mal phenotype of breast cancer
@en
P2093
Hidemi Hayashi
Hirokazu Ohata
Hitoshi Nakagama
Mari Hosonaga
Mikako Sasaki
Shinji Kuninaka
Takaaki M Goto
Tatsuhiro Shibata
Tatsuyuki Chiyoda
Yoichi Taya
P2860
P304
P356
10.1074/JBC.M111.313759
P407
P577
2012-01-19T00:00:00Z